Intra-Cellular Therapies

Intra-Cellular Therapies

Intra-Cellular Therapies

Type
B2c
Founded
2002
Raised
$210M
Follow us
Alexa global traffic share
03 Oct 2017
$150,000,000
Post-IPO equity
01 Sep 2013
$60,000,000
Secondary market